Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors

Details for Australian Patent Application No. 2009228325 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Kadow, John F.; Bender, John A.; Yang, Zhong

Agent A J Park

Pub. Number AU-A-2009228325

PCT Pub. Number WO2009/120733

Priority 61/039,973 27.03.08 US

Filing date 25 March 2009

Wipo publication date 1 October 2009

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/120733 Priority application(s): WO2009/120733

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228332-Battery pack management strategy in a hybrid electric motor vehicle

2009228323-Zymomonas with improved xylose utilization